StonvexLoading…
StonvexStonvexStonvexCore line items from NUE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-28 | Annual 2024 2024-06-29 |
|---|---|---|---|---|
Revenue | $32.49B | $30.73B | $7.44B | $8.08B |
Operating Income | $2.57B | $2.90B | Not available | Not available |
Net Income | $1.74B | $2.03B | $250.00M | $645.00M |
EPS (Diluted) | $7.52 | $8.46 | $1.05 | $2.68 |
Total Assets | $35.10B | $33.94B | Not available | Not available |
Total Liabilities | $12.98B | $12.52B | Not available | Not available |
Cash & Equivalents | $2.26B | $3.56B | Not available | Not available |
Free Cash Flow OCF − CapEx | $-188.00M | $806.00M | Not available | Not available |
Shares Outstanding | 231.00M | 238.50M | Not available | Not available |